Study to evaluate the safety, tolerability, PK, PD, and food effect of AMG 357 in healthy subjects
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
58
Research Site
Christchurch, New Zealand
Unnamed facility
Christchurch, New Zealand
Research Site
Grafton, Auckland, New Zealand
Safety and Tolerability
Examine the number of adverse events per subject, and subject incidence of clinically significant changes in physical examinations, vital signs, laboratory safety tests and electrocardiograms, after single and multiple dose administration of AMG 357 in healthy subjects.
Time frame: up to 35 days
Pharmacodynamics
Measure the area under the plasma concentration curve versus time of AMG 357 after single and multiple dose administration in healthy subjects
Time frame: up to 35 days
Effect of Food on AMG 357
To assess the effect of food on the PK parameters of AMG 357
Time frame: up to 11 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.